⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ZURA News
Zura Bio Limited Class A Ordinary Shares
Form 8-K
sec.gov
ZURA
Form 8-K
sec.gov
ZURA
Zura Bio to Present Phase 2 TibuSURE Study Design Poster Evaluating Dual IL-17A and BAFF Inhibition in Systemic Sclerosis at 9th Systemic Sclerosis World Congress
businesswire.com
ZURA
Zura Bio to Participate in Upcoming Investor Conferences
businesswire.com
ZURA
Zura Bio Announces Closing of its $144 Million Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
businesswire.com
ZURA
Zura Bio Announces Closing of its $144 Million Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
businesswire.com
ZURA
Form 8-K/A
sec.gov
ZURA
Form 8-K
sec.gov
ZURA
Zura Bio Announces Pricing of $125 Million Public Offering of Class A Ordinary Shares and Pre-Funded Warrants
businesswire.com
ZURA
Zura Bio Announces Pricing of $125 Million Public Offering of Class A Ordinary Shares and Pre-Funded Warrants
businesswire.com
ZURA